These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 17407002)
1. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. Geberhiwot T; Alger S; McKiernan P; Packard C; Caslake M; Elias E; Cramb R J Inherit Metab Dis; 2007 Jun; 30(3):406. PubMed ID: 17407002 [TBL] [Abstract][Full Text] [Related]
2. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III. Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362 [TBL] [Abstract][Full Text] [Related]
4. Hepatic ultrasound findings in the glycogen storage diseases. Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397 [TBL] [Abstract][Full Text] [Related]
5. Blood lipids and endothelial function in glycogen storage disease type III. Hershkovitz E; Donald A; Mullen M; Lee PJ; Leonard JV J Inherit Metab Dis; 1999 Dec; 22(8):891-8. PubMed ID: 10604141 [TBL] [Abstract][Full Text] [Related]
6. Glomerular and tubular function in glycogen storage disease. Lee PJ; Dalton RN; Shah V; Hindmarsh PC; Leonard JV Pediatr Nephrol; 1995 Dec; 9(6):705-10. PubMed ID: 8747109 [TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX. Cabrera-Abreu J; Crabtree NJ; Elias E; Fraser W; Cramb R; Alger S J Inherit Metab Dis; 2004; 27(1):1-9. PubMed ID: 14970741 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500 [TBL] [Abstract][Full Text] [Related]
9. Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia. Bandsma RH; Smit GP; Reijngoud DJ; Kuipers F J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S27-31. PubMed ID: 19267215 [TBL] [Abstract][Full Text] [Related]
10. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. Yekeler E; Dursun M; Emeksiz E; Akkoyunlu M; Akyol Y; Demir F; Gökcay G; Demirkol M Turk J Pediatr; 2007; 49(2):115-9. PubMed ID: 17907509 [TBL] [Abstract][Full Text] [Related]
11. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III. Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S J Trace Elem Med Biol; 2010 Jan; 24(1):42-5. PubMed ID: 20122579 [TBL] [Abstract][Full Text] [Related]
12. Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease). Wierzbicki AS; Watt GF; Lynas J; Winder AF; Wray R J Inherit Metab Dis; 2001 Oct; 24(5):527-34. PubMed ID: 11757580 [TBL] [Abstract][Full Text] [Related]
14. Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control. Bernier AV; Sentner CP; Correia CE; Theriaque DW; Shuster JJ; Smit GP; Weinstein DA J Inherit Metab Dis; 2008 Dec; 31(6):729-32. PubMed ID: 18709545 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Levy E; Thibault L; Turgeon J; Roy CC; Gurbindo C; Lepage G; Godard M; Rivard GE; Seidman E Am J Clin Nutr; 1993 Jun; 57(6):922-9. PubMed ID: 8503363 [TBL] [Abstract][Full Text] [Related]
16. Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis. Slonim AE; Coleman RA; Moses S; Bashan N; Shipp E; Mushlin P Metabolism; 1983 Jan; 32(1):70-4. PubMed ID: 6336817 [TBL] [Abstract][Full Text] [Related]
17. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Nagasaka H; Hirano K; Ohtake A; Miida T; Takatani T; Murayama K; Yorifuji T; Kobayashi K; Kanazawa M; Ogawa A; Takayanagi M Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455 [TBL] [Abstract][Full Text] [Related]
18. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Nguyen AD; Pan CJ; Weinstein DA; Chou JY Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453 [TBL] [Abstract][Full Text] [Related]